社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
jimcm
IP属地:未知
+关注
帖子 · 8
帖子 · 8
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
jimcm
jimcm
·
2021-10-07
👍
China tech names rally in morning trading
(Oct 7) China tech names rally in morning trading. Chinese technology stocks listed in the U.S. are
China tech names rally in morning trading
看
521
回复
评论
点赞
4
编组 21备份 2
分享
举报
jimcm
jimcm
·
2021-08-16
Ops
非常抱歉,此主贴已删除
看
530
回复
评论
点赞
1
编组 21备份 2
分享
举报
jimcm
jimcm
·
2021-08-11
Good call
Amazon to end relationship with Indian seller Cloudtail
NEW DELHI, Aug 9 (Reuters) - Amazon.com Inc and one of its biggest sellers in India, Cloudtail, have
Amazon to end relationship with Indian seller Cloudtail
看
596
回复
评论
点赞
1
编组 21备份 2
分享
举报
jimcm
jimcm
·
2021-08-04
Scam
Tesla Raises Prices Again - Here Are the Changes
Tesla continues to raise vehicle prices. Here are the latest changes to start off August. Throughou
Tesla Raises Prices Again - Here Are the Changes
看
520
回复
评论
点赞
1
编组 21备份 2
分享
举报
jimcm
jimcm
·
2021-08-04
No
非常抱歉,此主贴已删除
看
569
回复
1
点赞
点赞
编组 21备份 2
分享
举报
jimcm
jimcm
·
2021-08-03
Ooo
This Could Be Pfizer's Next COVID Blockbuster -- and It Isn't a Vaccine
Pfizer might not have to wait very long for this product to hit the market.
This Could Be Pfizer's Next COVID Blockbuster -- and It Isn't a Vaccine
看
471
回复
1
点赞
3
编组 21备份 2
分享
举报
jimcm
jimcm
·
2021-08-03
Wtf
Toplines Before US Market Open on Tuesday
Futures up: Dow 0.46%, S&P 0.37%, Nasdaq 0.16%. Chinese gaming stocks listed in the U.S. slump in pr
Toplines Before US Market Open on Tuesday
看
484
回复
评论
点赞
4
编组 21备份 2
分享
举报
jimcm
jimcm
·
2021-08-03
Wtf
Toplines Before US Market Open on Tuesday
Futures up: Dow 0.46%, S&P 0.37%, Nasdaq 0.16%. Chinese gaming stocks listed in the U.S. slump in pr
Toplines Before US Market Open on Tuesday
看
457
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4089870511727540","uuid":"4089870511727540","gmtCreate":1626767474182,"gmtModify":1628004308644,"name":"jimcm","pinyin":"jimcm","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/c32942224c09c28bda012467a9e0b80c","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":376,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":2,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":823662192,"gmtCreate":1633618844739,"gmtModify":1633618844811,"author":{"id":"4089870511727540","authorId":"4089870511727540","name":"jimcm","avatar":"https://static.tigerbbs.com/c32942224c09c28bda012467a9e0b80c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089870511727540","authorIdStr":"4089870511727540"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823662192","repostId":"1170144488","repostType":4,"repost":{"id":"1170144488","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633614175,"share":"https://ttm.financial/m/news/1170144488?lang=&edition=full","pubTime":"2021-10-07 21:42","market":"other","language":"en","title":"China tech names rally in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1170144488","media":"Tiger Newspress","summary":"(Oct 7) China tech names rally in morning trading.\n\nChinese technology stocks listed in the U.S. are","content":"<p>(Oct 7) China tech names rally in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/82f43fe405c7a1e296adb418a0267dda\" tg-width=\"343\" tg-height=\"843\" referrerpolicy=\"no-referrer\"></p>\n<p>Chinese technology stocks listed in the U.S. are signaling a third day of gains in moring trading after peers in Asia rallied on improved risk appetite.</p>\n<p>Shares in Pinduoduo Inc. rose 4.6% as of 9:44 a.m. in New York, while Alibaba Group Holding Ltd. climbed 5.67%. Other technology shares including Baidu Inc., Bilibili Inc. and DiDi Global Inc. were among American depositary receipts rising.</p>\n<p>Chinese technology stocks rebounded from a record low in Hong Kong on Thursday amid signs of renewed interest in one of China’s biggest tech names. Charlie Munger’s Daily Journal Corp. was reported to have increased its Alibaba stake by 83% last quarter.</p>\n<p><img src=\"https://static.tigerbbs.com/21da2b3e7cd8ae63e949304ad3076747\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\">The Nasdaq Golden Dragon China Index -- which tracks several firms listed in the U.S. that conduct a majority of their business in China -- has also climbed for the past two days. Yet despite this week’s brief respite, the gauge remains deeply in the red year-to-date, having fallen 35%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China tech names rally in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina tech names rally in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-07 21:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Oct 7) China tech names rally in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/82f43fe405c7a1e296adb418a0267dda\" tg-width=\"343\" tg-height=\"843\" referrerpolicy=\"no-referrer\"></p>\n<p>Chinese technology stocks listed in the U.S. are signaling a third day of gains in moring trading after peers in Asia rallied on improved risk appetite.</p>\n<p>Shares in Pinduoduo Inc. rose 4.6% as of 9:44 a.m. in New York, while Alibaba Group Holding Ltd. climbed 5.67%. Other technology shares including Baidu Inc., Bilibili Inc. and DiDi Global Inc. were among American depositary receipts rising.</p>\n<p>Chinese technology stocks rebounded from a record low in Hong Kong on Thursday amid signs of renewed interest in one of China’s biggest tech names. Charlie Munger’s Daily Journal Corp. was reported to have increased its Alibaba stake by 83% last quarter.</p>\n<p><img src=\"https://static.tigerbbs.com/21da2b3e7cd8ae63e949304ad3076747\" tg-width=\"1200\" tg-height=\"675\" referrerpolicy=\"no-referrer\">The Nasdaq Golden Dragon China Index -- which tracks several firms listed in the U.S. that conduct a majority of their business in China -- has also climbed for the past two days. Yet despite this week’s brief respite, the gauge remains deeply in the red year-to-date, having fallen 35%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170144488","content_text":"(Oct 7) China tech names rally in morning trading.\n\nChinese technology stocks listed in the U.S. are signaling a third day of gains in moring trading after peers in Asia rallied on improved risk appetite.\nShares in Pinduoduo Inc. rose 4.6% as of 9:44 a.m. in New York, while Alibaba Group Holding Ltd. climbed 5.67%. Other technology shares including Baidu Inc., Bilibili Inc. and DiDi Global Inc. were among American depositary receipts rising.\nChinese technology stocks rebounded from a record low in Hong Kong on Thursday amid signs of renewed interest in one of China’s biggest tech names. Charlie Munger’s Daily Journal Corp. was reported to have increased its Alibaba stake by 83% last quarter.\nThe Nasdaq Golden Dragon China Index -- which tracks several firms listed in the U.S. that conduct a majority of their business in China -- has also climbed for the past two days. Yet despite this week’s brief respite, the gauge remains deeply in the red year-to-date, having fallen 35%.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":521,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":839375794,"gmtCreate":1629124473918,"gmtModify":1631889501850,"author":{"id":"4089870511727540","authorId":"4089870511727540","name":"jimcm","avatar":"https://static.tigerbbs.com/c32942224c09c28bda012467a9e0b80c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089870511727540","authorIdStr":"4089870511727540"},"themes":[],"htmlText":"Ops","listText":"Ops","text":"Ops","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/839375794","repostId":"2159224290","repostType":2,"isVote":1,"tweetType":1,"viewCount":530,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892703054,"gmtCreate":1628687884578,"gmtModify":1631889501857,"author":{"id":"4089870511727540","authorId":"4089870511727540","name":"jimcm","avatar":"https://static.tigerbbs.com/c32942224c09c28bda012467a9e0b80c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089870511727540","authorIdStr":"4089870511727540"},"themes":[],"htmlText":"Good call","listText":"Good call","text":"Good call","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/892703054","repostId":"2158478684","repostType":2,"repost":{"id":"2158478684","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1628521279,"share":"https://ttm.financial/m/news/2158478684?lang=&edition=full","pubTime":"2021-08-09 23:01","market":"us","language":"en","title":"Amazon to end relationship with Indian seller Cloudtail","url":"https://stock-news.laohu8.com/highlight/detail?id=2158478684","media":"Reuters","summary":"NEW DELHI, Aug 9 (Reuters) - Amazon.com Inc and one of its biggest sellers in India, Cloudtail, have","content":"<p>NEW DELHI, Aug 9 (Reuters) - Amazon.com Inc and <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its biggest sellers in India, Cloudtail, have decided to end their relationship, they said on Monday, following years of allegations from brick-and-mortar retailers that the seller received preferential treatment.</p>\n<p>A joint venture between Amazon and India's Catamaran that controlled Cloudtail was coming up for renewal on May 19, 2022, and the two sides said in a joint statement they had mutually decided not to extend it beyond that date.</p>\n<p>The decision comes after a Reuters investigation in February based on Amazon documents showed the U.S. company had given preferential treatment for years to a small group of sellers, including Cloudtail, and used them to bypass Indian laws.</p>\n<p>Amazon has said it does not give preferential treatment to any seller and that it complies with the law.</p>\n<p>In their joint statement, Amazon and Catamaran did not say why they had decided to end their joint venture, but said the partnership ran successfully for seven years and made \"tremendous strides.\"</p>\n<p>Cloudtail had been controversial, with Indian brick-and-mortar retailers for years accusing Amazon of giving it preferential treatment which hurt smaller retailers.</p>\n<p>It was formed when Amazon entered a joint venture with an entity formed by one of India’s most famous tech moguls, N.R. Narayana Murthy, which was then used to create Cloudtail, which began offering goods on Amazon.in after it was set up in August 2014.</p>\n<p>The Reuters investigation in February found Amazon publicly called Cloudtail an independent seller offering goods on its marketplace website, but internal company documents revealed the U.S. company was deeply involved in expanding it and used it, among other sellers, to circumvent the country's foreign investment laws.</p>\n<p>The story had triggered calls for a ban and an investigation of Amazon, and the financial crime fighting agency was looking into its findings.</p>\n<p>Amazon also gave Cloudtail, and another seller named Appario, discounted fees, the Reuters investigation found.</p>\n<p>Amazon is also in talks with the parent of Appario to determine whether it wants to renew its joint venture next year, a source with direct knowledge told Reuters on Monday. Appario did not immediately respond to a request for comment.</p>\n<p>The source added that multiple sellers in India were likely to take over Cloudtail's share on Amazon.in over time.</p>\n<p>\"There will be challenges, but the company is fairly confident it will manage,\" the source added.</p>\n<p>Separately, India's Supreme Court on Monday ruled that Amazon and Walmart's Flipkart will have to face antitrust investigations ordered against them in India, dealing a blow to the companies in their key growth market.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon to end relationship with Indian seller Cloudtail</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon to end relationship with Indian seller Cloudtail\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-09 23:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW DELHI, Aug 9 (Reuters) - Amazon.com Inc and <a href=\"https://laohu8.com/S/AONE.U\">one</a> of its biggest sellers in India, Cloudtail, have decided to end their relationship, they said on Monday, following years of allegations from brick-and-mortar retailers that the seller received preferential treatment.</p>\n<p>A joint venture between Amazon and India's Catamaran that controlled Cloudtail was coming up for renewal on May 19, 2022, and the two sides said in a joint statement they had mutually decided not to extend it beyond that date.</p>\n<p>The decision comes after a Reuters investigation in February based on Amazon documents showed the U.S. company had given preferential treatment for years to a small group of sellers, including Cloudtail, and used them to bypass Indian laws.</p>\n<p>Amazon has said it does not give preferential treatment to any seller and that it complies with the law.</p>\n<p>In their joint statement, Amazon and Catamaran did not say why they had decided to end their joint venture, but said the partnership ran successfully for seven years and made \"tremendous strides.\"</p>\n<p>Cloudtail had been controversial, with Indian brick-and-mortar retailers for years accusing Amazon of giving it preferential treatment which hurt smaller retailers.</p>\n<p>It was formed when Amazon entered a joint venture with an entity formed by one of India’s most famous tech moguls, N.R. Narayana Murthy, which was then used to create Cloudtail, which began offering goods on Amazon.in after it was set up in August 2014.</p>\n<p>The Reuters investigation in February found Amazon publicly called Cloudtail an independent seller offering goods on its marketplace website, but internal company documents revealed the U.S. company was deeply involved in expanding it and used it, among other sellers, to circumvent the country's foreign investment laws.</p>\n<p>The story had triggered calls for a ban and an investigation of Amazon, and the financial crime fighting agency was looking into its findings.</p>\n<p>Amazon also gave Cloudtail, and another seller named Appario, discounted fees, the Reuters investigation found.</p>\n<p>Amazon is also in talks with the parent of Appario to determine whether it wants to renew its joint venture next year, a source with direct knowledge told Reuters on Monday. Appario did not immediately respond to a request for comment.</p>\n<p>The source added that multiple sellers in India were likely to take over Cloudtail's share on Amazon.in over time.</p>\n<p>\"There will be challenges, but the company is fairly confident it will manage,\" the source added.</p>\n<p>Separately, India's Supreme Court on Monday ruled that Amazon and Walmart's Flipkart will have to face antitrust investigations ordered against them in India, dealing a blow to the companies in their key growth market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158478684","content_text":"NEW DELHI, Aug 9 (Reuters) - Amazon.com Inc and one of its biggest sellers in India, Cloudtail, have decided to end their relationship, they said on Monday, following years of allegations from brick-and-mortar retailers that the seller received preferential treatment.\nA joint venture between Amazon and India's Catamaran that controlled Cloudtail was coming up for renewal on May 19, 2022, and the two sides said in a joint statement they had mutually decided not to extend it beyond that date.\nThe decision comes after a Reuters investigation in February based on Amazon documents showed the U.S. company had given preferential treatment for years to a small group of sellers, including Cloudtail, and used them to bypass Indian laws.\nAmazon has said it does not give preferential treatment to any seller and that it complies with the law.\nIn their joint statement, Amazon and Catamaran did not say why they had decided to end their joint venture, but said the partnership ran successfully for seven years and made \"tremendous strides.\"\nCloudtail had been controversial, with Indian brick-and-mortar retailers for years accusing Amazon of giving it preferential treatment which hurt smaller retailers.\nIt was formed when Amazon entered a joint venture with an entity formed by one of India’s most famous tech moguls, N.R. Narayana Murthy, which was then used to create Cloudtail, which began offering goods on Amazon.in after it was set up in August 2014.\nThe Reuters investigation in February found Amazon publicly called Cloudtail an independent seller offering goods on its marketplace website, but internal company documents revealed the U.S. company was deeply involved in expanding it and used it, among other sellers, to circumvent the country's foreign investment laws.\nThe story had triggered calls for a ban and an investigation of Amazon, and the financial crime fighting agency was looking into its findings.\nAmazon also gave Cloudtail, and another seller named Appario, discounted fees, the Reuters investigation found.\nAmazon is also in talks with the parent of Appario to determine whether it wants to renew its joint venture next year, a source with direct knowledge told Reuters on Monday. Appario did not immediately respond to a request for comment.\nThe source added that multiple sellers in India were likely to take over Cloudtail's share on Amazon.in over time.\n\"There will be challenges, but the company is fairly confident it will manage,\" the source added.\nSeparately, India's Supreme Court on Monday ruled that Amazon and Walmart's Flipkart will have to face antitrust investigations ordered against them in India, dealing a blow to the companies in their key growth market.","news_type":1,"symbols_score_info":{"AMZN":0.9}},"isVote":1,"tweetType":1,"viewCount":596,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890055743,"gmtCreate":1628069830182,"gmtModify":1631889501870,"author":{"id":"4089870511727540","authorId":"4089870511727540","name":"jimcm","avatar":"https://static.tigerbbs.com/c32942224c09c28bda012467a9e0b80c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089870511727540","authorIdStr":"4089870511727540"},"themes":[],"htmlText":"Scam","listText":"Scam","text":"Scam","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/890055743","repostId":"1180549619","repostType":2,"repost":{"id":"1180549619","kind":"news","pubTimestamp":1628066563,"share":"https://ttm.financial/m/news/1180549619?lang=&edition=full","pubTime":"2021-08-04 16:42","market":"us","language":"en","title":"Tesla Raises Prices Again - Here Are the Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1180549619","media":"The Street","summary":"Tesla continues to raise vehicle prices. Here are the latest changes to start off August.\n\nThroughou","content":"<blockquote>\n Tesla continues to raise vehicle prices. Here are the latest changes to start off August.\n</blockquote>\n<p>Throughout the year, Tesla has consistently been raising prices across their vehicle lineup. A few days into the third quarter, the trend has continued. The latest price increases are to the<b>Model S</b>and<b>Model X</b>.</p>\n<p><b>Changes</b></p>\n<p>Long Range Model S price increased by<b>$5,000</b>, from $84,990 to $89,990.</p>\n<p>Long Range Model X price increased by<b>$5,000</b>, from $94,990 to $99,990.</p>\n<p>Tesla did not adjust pricing on the Plaid versions of S/X. Model 3 and Model Y prices were unchanged. The table below shows Tesla's price adjustments in the US this year.</p>\n<p><img src=\"https://static.tigerbbs.com/eec692db083dbbfbcaccb65bacc1a05c\" tg-width=\"700\" tg-height=\"201\" width=\"100%\" height=\"auto\"><i>Q1 adjustments are hidden due to space constraints.</i></p>\n<p>While it had not been entirely clear whether Tesla's continued price increases were due to rising costs, rising demand, or both, Tesla'sstrong Q2 earnings report suggests the adjustments are more of a reflection on demand. Tesla CFO Zach Kirkhorn noted that Q2 resulted in Tesla's best automotive gross margin (excluding regulatory credit sales) since the introduction of the Model 3.</p>\n<p>Tesla did acknowledge losses on the Model S and Model X lineup in both the first and second quarters of 2021, but the losses were primarily due to low levels of production as Tesla ramps up following the refresh of both vehicles.</p>\n<p>Currently, Tesla estimates new orders for Long Range Model S and Model X won't be fulfilled until February-March of next year. With such a long order backlog, Tesla is in a strong position to raise prices.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title> Tesla Raises Prices Again - Here Are the Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n Tesla Raises Prices Again - Here Are the Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-04 16:42 GMT+8 <a href=https://www.thestreet.com/tesla/news/tesla-raises-prices-again-august-week-1><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla continues to raise vehicle prices. Here are the latest changes to start off August.\n\nThroughout the year, Tesla has consistently been raising prices across their vehicle lineup. A few days into ...</p>\n\n<a href=\"https://www.thestreet.com/tesla/news/tesla-raises-prices-again-august-week-1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.thestreet.com/tesla/news/tesla-raises-prices-again-august-week-1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180549619","content_text":"Tesla continues to raise vehicle prices. Here are the latest changes to start off August.\n\nThroughout the year, Tesla has consistently been raising prices across their vehicle lineup. A few days into the third quarter, the trend has continued. The latest price increases are to theModel SandModel X.\nChanges\nLong Range Model S price increased by$5,000, from $84,990 to $89,990.\nLong Range Model X price increased by$5,000, from $94,990 to $99,990.\nTesla did not adjust pricing on the Plaid versions of S/X. Model 3 and Model Y prices were unchanged. The table below shows Tesla's price adjustments in the US this year.\nQ1 adjustments are hidden due to space constraints.\nWhile it had not been entirely clear whether Tesla's continued price increases were due to rising costs, rising demand, or both, Tesla'sstrong Q2 earnings report suggests the adjustments are more of a reflection on demand. Tesla CFO Zach Kirkhorn noted that Q2 resulted in Tesla's best automotive gross margin (excluding regulatory credit sales) since the introduction of the Model 3.\nTesla did acknowledge losses on the Model S and Model X lineup in both the first and second quarters of 2021, but the losses were primarily due to low levels of production as Tesla ramps up following the refresh of both vehicles.\nCurrently, Tesla estimates new orders for Long Range Model S and Model X won't be fulfilled until February-March of next year. With such a long order backlog, Tesla is in a strong position to raise prices.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":520,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":890052446,"gmtCreate":1628069725885,"gmtModify":1631889501868,"author":{"id":"4089870511727540","authorId":"4089870511727540","name":"jimcm","avatar":"https://static.tigerbbs.com/c32942224c09c28bda012467a9e0b80c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089870511727540","authorIdStr":"4089870511727540"},"themes":[],"htmlText":"No","listText":"No","text":"No","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/890052446","repostId":"1115159207","repostType":2,"isVote":1,"tweetType":1,"viewCount":569,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807918810,"gmtCreate":1627995970230,"gmtModify":1631889501865,"author":{"id":"4089870511727540","authorId":"4089870511727540","name":"jimcm","avatar":"https://static.tigerbbs.com/c32942224c09c28bda012467a9e0b80c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089870511727540","authorIdStr":"4089870511727540"},"themes":[],"htmlText":"Ooo","listText":"Ooo","text":"Ooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/807918810","repostId":"2156147918","repostType":4,"repost":{"id":"2156147918","kind":"highlight","pubTimestamp":1627994460,"share":"https://ttm.financial/m/news/2156147918?lang=&edition=full","pubTime":"2021-08-03 20:41","market":"us","language":"en","title":"This Could Be Pfizer's Next COVID Blockbuster -- and It Isn't a Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2156147918","media":"Motley Fool","summary":"Pfizer might not have to wait very long for this product to hit the market.","content":"<p>In 2019 and 2020, <b>Pfizer</b>'s (NYSE:PFE) top-selling product was pneumococcal vaccine Prevnar 13. It generated over $5.8 billion in sales in both years. That's a lot of money for a very successful product.</p>\n<p>But Prevnar 13 is no longer Pfizer's top-selling product. The COVID-19 vaccine BNT162b2, developed by Pfizer and <b>BioNTech</b> (NASDAQ:BNTX), generated sales of $7.8 billion in the first half of 2021 alone. Pfizer expects the vaccine will rake in $33.5 billion over the entire year. Even with the company splitting profits with BioNTech, Pfizer should conservatively make in the ballpark of $17 billion from BNT162b2 this year.</p>\n<p>Even more money could be on the way. Pfizer is busy working on its next potential COVID-19 blockbuster -- and it isn't a vaccine.</p>\n<p><img src=\"https://static.tigerbbs.com/2e39eb3485964eb8dab974f72921be8b\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Stopping the coronavirus in its tracks</h3>\n<p>Pfizer has stated for a while that it wouldn't restrict its efforts to fight COVID-19 to only vaccines. It has also focused on developing potential treatments for the infectious disease. The company provided an update on <a href=\"https://laohu8.com/S/AONE.U\">one</a> especially promising therapy in its second-quarter conference call last week.</p>\n<p>Protease inhibitors are a class of antiviral drugs that have been effective in treating HIV and hepatitis C. These therapies bind to protease enzymes in viruses and prevent the virus from replicating.</p>\n<p>Pfizer initiated an early stage clinical study evaluating oral protease inhibitor PF-07321332 in March of this year. The company had good news to report from that study in its Q2 update.</p>\n<p>Chief scientific officer Mikael Dolsten said that in the phase 1 study, PF-07321332 exceeded the level predicted to inhibit coronavirus viral replication by more than fivefold. Dolsten also stated that the experimental protease inhibitor showed powerful antiviral activity in preclinical testing that could be effective against \"all currently known COVID-19 variants.\"</p>\n<p>So far, the experimental antiviral drug appears to have a good safety profile. Dolsten said that there haven't been any safety issues in giving doses of up to 500 milligrams twice per day over a 10-day period.</p>\n<p>Based on these encouraging results, Pfizer advanced the oral protease inhibitor into phase 2/3 testing in July. The company will evaluate PF-07321332 in five-day and 10-day treatments for individuals who have been in close contact with someone with COVID-19.</p>\n<h3>A big market opportunity</h3>\n<p>Pfizer estimates that the addressable market for its protease inhibitor could be in the hundreds of millions of patients. That doesn't seem farfetched considering the rapid spread of COVID-19 exposure due to the delta variant.</p>\n<p>The U.S. Food and Drug Administration (FDA) has already granted Emergency Use Authorization (EUA) to <b>Regeneron</b>'s (NASDAQ:REGN) antibody cocktail REGEN-COV as a treatment for hospitalized COVID-19 patients and for post-exposure prophylaxis. However, there are a few drawbacks to Regeneron's therapy.</p>\n<p>First, REGEN-COV is expensive -- more than $2,000 per dose. Second, it must be administered via infusion or subcutaneous injection. Third, the current U.S. EUA for post-exposure prophylaxis only applies to individuals who have been exposed to COVID-19 who have a high risk of developing COVID-19 and who haven't been fully vaccinated.</p>\n<p>Pfizer's PF-07321332 would be much more convenient than REGEN-COV since it's taken orally. Although the big drugmaker hasn't given any hints about what the pricing for the antiviral therapy might be should it win EUA or approval, a lower price tag could open up a wide market that might include lower-risk individuals who are exposed to COVID-19.</p>\n<h3>Coming soon?</h3>\n<p>There shouldn't be a long wait for Pfizer's next potential COVID-19 blockbuster. Assuming the phase 2/3 testing goes well, the company thinks that it will be able to file for U.S. EUA in the fourth quarter of this year.</p>\n<p>Pfizer CEO Albert Bourla said in the company's Q2 call that he's given the green light to manufacture \"significant quantities\" of the oral protease inhibitor so that large volumes of doses will be available if EUA is granted. He added that Pfizer is absorbing the risk of making this investment because \"it is the right thing to do.\"</p>\n<p>PF-07321332 probably won't be as big a catalyst for the big pharma stock as the Pfizer-BioNTech COVID-19 vaccine. However, Pfizer won't have to split the profits on the oral therapy as it does with BNT162b2. If the company's late-stage testing of the COVID-19 drug is successful, Pfizer seems very likely to have another blockbuster on its hands in 2022.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Could Be Pfizer's Next COVID Blockbuster -- and It Isn't a Vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Could Be Pfizer's Next COVID Blockbuster -- and It Isn't a Vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-03 20:41 GMT+8 <a href=https://www.fool.com/investing/2021/08/03/this-could-be-pfizers-next-covid-blockbuster-and-i/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In 2019 and 2020, Pfizer's (NYSE:PFE) top-selling product was pneumococcal vaccine Prevnar 13. It generated over $5.8 billion in sales in both years. That's a lot of money for a very successful ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/03/this-could-be-pfizers-next-covid-blockbuster-and-i/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/08/03/this-could-be-pfizers-next-covid-blockbuster-and-i/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156147918","content_text":"In 2019 and 2020, Pfizer's (NYSE:PFE) top-selling product was pneumococcal vaccine Prevnar 13. It generated over $5.8 billion in sales in both years. That's a lot of money for a very successful product.\nBut Prevnar 13 is no longer Pfizer's top-selling product. The COVID-19 vaccine BNT162b2, developed by Pfizer and BioNTech (NASDAQ:BNTX), generated sales of $7.8 billion in the first half of 2021 alone. Pfizer expects the vaccine will rake in $33.5 billion over the entire year. Even with the company splitting profits with BioNTech, Pfizer should conservatively make in the ballpark of $17 billion from BNT162b2 this year.\nEven more money could be on the way. Pfizer is busy working on its next potential COVID-19 blockbuster -- and it isn't a vaccine.\n\nImage source: Getty Images.\nStopping the coronavirus in its tracks\nPfizer has stated for a while that it wouldn't restrict its efforts to fight COVID-19 to only vaccines. It has also focused on developing potential treatments for the infectious disease. The company provided an update on one especially promising therapy in its second-quarter conference call last week.\nProtease inhibitors are a class of antiviral drugs that have been effective in treating HIV and hepatitis C. These therapies bind to protease enzymes in viruses and prevent the virus from replicating.\nPfizer initiated an early stage clinical study evaluating oral protease inhibitor PF-07321332 in March of this year. The company had good news to report from that study in its Q2 update.\nChief scientific officer Mikael Dolsten said that in the phase 1 study, PF-07321332 exceeded the level predicted to inhibit coronavirus viral replication by more than fivefold. Dolsten also stated that the experimental protease inhibitor showed powerful antiviral activity in preclinical testing that could be effective against \"all currently known COVID-19 variants.\"\nSo far, the experimental antiviral drug appears to have a good safety profile. Dolsten said that there haven't been any safety issues in giving doses of up to 500 milligrams twice per day over a 10-day period.\nBased on these encouraging results, Pfizer advanced the oral protease inhibitor into phase 2/3 testing in July. The company will evaluate PF-07321332 in five-day and 10-day treatments for individuals who have been in close contact with someone with COVID-19.\nA big market opportunity\nPfizer estimates that the addressable market for its protease inhibitor could be in the hundreds of millions of patients. That doesn't seem farfetched considering the rapid spread of COVID-19 exposure due to the delta variant.\nThe U.S. Food and Drug Administration (FDA) has already granted Emergency Use Authorization (EUA) to Regeneron's (NASDAQ:REGN) antibody cocktail REGEN-COV as a treatment for hospitalized COVID-19 patients and for post-exposure prophylaxis. However, there are a few drawbacks to Regeneron's therapy.\nFirst, REGEN-COV is expensive -- more than $2,000 per dose. Second, it must be administered via infusion or subcutaneous injection. Third, the current U.S. EUA for post-exposure prophylaxis only applies to individuals who have been exposed to COVID-19 who have a high risk of developing COVID-19 and who haven't been fully vaccinated.\nPfizer's PF-07321332 would be much more convenient than REGEN-COV since it's taken orally. Although the big drugmaker hasn't given any hints about what the pricing for the antiviral therapy might be should it win EUA or approval, a lower price tag could open up a wide market that might include lower-risk individuals who are exposed to COVID-19.\nComing soon?\nThere shouldn't be a long wait for Pfizer's next potential COVID-19 blockbuster. Assuming the phase 2/3 testing goes well, the company thinks that it will be able to file for U.S. EUA in the fourth quarter of this year.\nPfizer CEO Albert Bourla said in the company's Q2 call that he's given the green light to manufacture \"significant quantities\" of the oral protease inhibitor so that large volumes of doses will be available if EUA is granted. He added that Pfizer is absorbing the risk of making this investment because \"it is the right thing to do.\"\nPF-07321332 probably won't be as big a catalyst for the big pharma stock as the Pfizer-BioNTech COVID-19 vaccine. However, Pfizer won't have to split the profits on the oral therapy as it does with BNT162b2. If the company's late-stage testing of the COVID-19 drug is successful, Pfizer seems very likely to have another blockbuster on its hands in 2022.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807911385,"gmtCreate":1627995903547,"gmtModify":1631889501867,"author":{"id":"4089870511727540","authorId":"4089870511727540","name":"jimcm","avatar":"https://static.tigerbbs.com/c32942224c09c28bda012467a9e0b80c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089870511727540","authorIdStr":"4089870511727540"},"themes":[],"htmlText":"Wtf","listText":"Wtf","text":"Wtf","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/807911385","repostId":"1126095878","repostType":4,"repost":{"id":"1126095878","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627991741,"share":"https://ttm.financial/m/news/1126095878?lang=&edition=full","pubTime":"2021-08-03 19:55","market":"us","language":"en","title":"Toplines Before US Market Open on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1126095878","media":"Tiger Newspress","summary":"Futures up: Dow 0.46%, S&P 0.37%, Nasdaq 0.16%.\nChinese gaming stocks listed in the U.S. slump in pr","content":"<ul>\n <li>Futures up: Dow 0.46%, S&P 0.37%, <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> 0.16%.</li>\n <li>Chinese gaming stocks listed in the U.S. slump in premarket trading.</li>\n <li><a href=\"https://laohu8.com/S/UA.C\">Under Armour</a>, Translate Bio, <a href=\"https://laohu8.com/S/CLX\">Clorox</a> and more made the biggest moves in the premarket.</li>\n <li>Crude oil reversed earlier losses as sentiment improved in broader markets.</li>\n</ul>\n<p>(August 3) U.S. stock index futures rose on Tuesday, as an upbeat corporate earnings season and a pickup in global deals activity lifted demand for risky equities, although gains were capped by concerns around a surge in the Delta variant of the coronavirus.</p>\n<p>At 08:02 a.m. ET, Dow E-minis were up 159 points, or 0.46%, S&P 500 E-minis were up 16 points, or 0.37% and Nasdaq 100 E-minis rose 24.5 points, or 0.16%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/041b88ace41d9b6a718971a4da2e78b4\" tg-width=\"1242\" tg-height=\"484\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:02</span></p>\n<p>The big story overnight was <a href=\"https://laohu8.com/S/CAAS\">China</a>'s latest crackdown in which the XInhua-affiliated Economic <a href=\"https://laohu8.com/S/III\">Information</a> Daily cited Tencent's \"Honor of Kings\" in an article in which it said minors were addicted to online games and called for more curbs on the industry. The broadside re-ignited investor fears about state intervention in China after Beijing had already targeted the property, education and technology sectors to curb cost pressures and reassert the primacy of socialism after years of runaway market growth. \"They don’t believe anything is off limit and will react, sometimes overreact, to anything on state media that fits the tech crackdown narrative,” Ether Yin, partner at Trivium, a Beijing-based consultancy.</p>\n<p>Not surprisingly, Chinese gaming stocks listed in the U.S. slump in premarket trading; among the biggest gaming-related stocks falling this morning, <a href=\"https://laohu8.com/S/NTES\">NetEase</a> sinks 8.8%, Bilibili falls 6.67%, Huya declines 4.79% and <a href=\"https://laohu8.com/S/DOYU\">DouYu</a> International slides 5.12% as of 8:11am in <a href=\"https://laohu8.com/S/NWY\">New York</a>, Other large-cap Chinese stocks are also lower in U.S. premarket trading: <a href=\"https://laohu8.com/S/BABA\">Alibaba</a> -0.94%, Pinduoduo -1.2%, Baidu -0.37%, Didi -1.25%.</p>\n<p><img src=\"https://static.tigerbbs.com/7d28ab254bf7e852d939886a935a67a2\" tg-width=\"373\" tg-height=\"642\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves in the premarket: <a href=\"https://laohu8.com/S/UA\">Under Armour</a>, Translate Bio, Clorox and more</b></p>\n<p><b>1) Under Armour(UAA)</b> – Under Armour shares jumped 4.5% in the premarket, after the athletic apparel maker beat estimates on the top and bottom lines and the company raised its full-year forecast. Under Armour reported quarterly earnings of 24 cents per share, compared to a consensus estimate of 6 cents a share.</p>\n<p><b>2) Translate Bio(TBIO)</b> – French drugmakerSanofi(SNY) agreed to buy the U.S.-based biotech company for $3.2 billion, or $38 per share in cash. Translate Bio specializes in mRNA technology, the type that was used to produce thePfizerandModernaCovid-19 vaccines. Translate Bio shares soared 29.6% in premarket trading.</p>\n<p><b>3) Clorox(CLX) </b>– Clorox tumbled 8.6% in premarket action after the household products maker missed top and bottom line estimates for its latest quarter. Clorox’s sales fell from a year ago, when consumers stocked up on its products amid the surging pandemic.</p>\n<p><b>4) Eli Lilly(LLY) </b>– The drugmaker’s shares lost 1.7% in premarket trading, after falling 2 cents a share shy of estimates, with quarterly earnings of $1.87 per share. Revenue beat forecasts, but Lilly’s overall results were impacted by weaker sales of Covid-19 therapies as more Americans got vaccinated.</p>\n<p><b>5) <a href=\"https://laohu8.com/S/MAR\">Marriott</a>(MAR)</b> – The hotel operator’s stock gained 1.8% in premarket trading after it reported quarterly earnings of 79 cents per share, compared to a 45 cents a share consensus estimate. Revenue more than doubled from a year ago thanks to a rebound in travel demand, though it did fall slightly short of Wall Street forecasts.</p>\n<p><b>6) <a href=\"https://laohu8.com/S/TTWO\">Take-Two</a> Interactive(TTWO)</b> – Take-<a href=\"https://laohu8.com/S/TWOA.U\">Two</a> lost 4.3% premarket trading after issuing a weaker-than-expected outlook and announcing delays in new releases for some of its games. The video game producer beat estimates by 12 cents a share, with quarterly profit of $1.01 per share. Take-<a href=\"https://laohu8.com/S/TWOA\">Two</a>’s revenue also topped Wall Street forecasts.</p>\n<p><b>7) BP(BP)</b> – BP surged 6.3% in premarket trading after it reported better-than-expected quarterly profit and revenue, thanks to higher oil and gas prices. The energy producer also announced a 4% dividend hike and a boost to its share buyback program.</p>\n<p><b>8) Stellantis(STLA) </b>– Stellantis raised its full-year profit margin outlook after the automaker reported strong first-half financial results, boosted by record margins in North America. The upbeat results came despite the impact of the global chip shortage which cut production by 700,000 vehicles. The stock rallied 5.3% in the premarket.</p>\n<p><b>9) <a href=\"https://laohu8.com/S/MU\">Micron Technology</a>(MU)</b> – Micron instituted its first-ever dividend, with the chip maker planning to pay 10 cents per share in cash payable on October 18. Micron also said it had updated its share buyback policy to buy more when prices are low and fewer when prices are high. Micron shares gained 1.9% in the premarket.</p>\n<p><b>10) <a href=\"https://laohu8.com/S/SPG\">Simon Property</a> Group(SPG)</b> – Simon Property shares rose 2.8% in premarket trading after it said sales at its shopping centers returned to pre-pandemic levels in June. The largest U.S. mall owner is hoping the improved results encourage retailers to sign new leases and help it fill space vacated during the pandemic.</p>\n<p><b>11) <a href=\"https://laohu8.com/S/SEDG\">SolarEdge</a> Technologies(SEDG) </b>– SolarEdge reported better-than-expected earnings and revenue for its latest quarter, with the solar energy company also providing an upbeat current-quarter forecast. SolarEdge surged 11.4% in the premarket.</p>\n<p><b>12) Reynolds Consumer Products(REYN)</b> – Reynolds beat estimates by a penny a share, with quarterly earnings of 39 cents per share. Revenue fell short of Street forecasts, however. The maker of products like Hefty garbage bags and Reynolds Wrap said it was pleased with the results in the face of higher input costs supply chain issues. Reynolds lost 3.6% in premarket action.</p>\n<p><b>In rates,</b> treasuries drifted lower over early European session, tracking losses in bunds and gilts. The 10-year U.S. Treasury yield edged around 2bps higher after falling as low as 1.15%; the move steepened 2s10s, 5s30s by 1bp each. Higher S&P futures also added pressure on rising yields, following gains across European stocks amid positive earnings results. Germany’s 10-year yield fell to its lowest since early February at -0.486%. It was last up less than a basis point at -0.47%. Its 30-year yield, which turned negative and sent the whole German yield curve into negative territory on Monday, was hovering around 0%.</p>\n<p>“There is some definite downside bias in the dollar now,” said Vasileios Gkionakis, Global Head of FX Strategy at fund manager Lombard Odier in Switzerland. “You are starting to a see a rotation of growth away from the U.S.”</p>\n<p>According to strategists the months-long advance in Treasuries which saw 10Y real yields drop to fresh record lows on Monday, points to worries that a weaker period lies ahead for the economic reopening from the health crisis, though second-quarter corporate earnings have been robust for the most part. Traders are awaiting key U.S. jobs data this week to gauge the recovery and monitoring the impact of price pressures sparked by pandemic-related disruption and bottlenecks.</p>\n<p>“I don’t think the market is concerned about delta as much as it’s concerned about how it impacts inflation,” Shana Sissel, Spotlight Asset Group chief investment officer, said on Bloomberg Television, referring to the coronavirus variant. “The longer we have delta spread globally, the longer the supply chain disruptions will continue.”</p>\n<p>Meanwhile, on the policy front, the tapering debate continues. Federal Reserve Governor Christopher Waller said he could back a tapering announcement by September, if the next two monthly U.S. employment reports show continued gains.</p>\n<p><b>In FX, </b>the Norwegian krone and <a href=\"https://laohu8.com/S/NGD\">New</a> Zealand’s dollar led an advance against the greenback; the Canadian dollar retreated, underperforming its peers. The euro eked out an advance to a session high of 1.1885 per dollar; the pound climbed back above $1.39 and gilts halted a three-day gain as caution reigns ahead of Bank of England’s meeting on Thursday.<b>The Australian dollar jumped after the nation’s central bank said it will stick to its tapering plan, arguing that the economy will rebound from the latest virus outbreak.</b>Traders rushed to close short positions on the Aussie after the Reserve Bank of Australia decision on Tuesday, according to Asia-based FX traders. Existing AUD/NZD flows after the RBA decision propelled New Zealand’s dollar to a new session high.</p>\n<p>Australia’s currency advanced after its central bank kept a plan to taper bond purchases despite a protracted lockdown in Sydney.</p>\n<p><b>In commodities, </b>crude oil reversed earlier losses as sentiment improved in broader markets even though the spread of the delta coronavirus variant, including in the key market of China, continues to pose a risk to demand. Brent crude was up 33 cents in London at $73.28 per barrel. U.S. crude inched up to $71.56 a barrel while gold and industrial metal copper were both slightly lower at $1,810.45 per ounce and 9,594.50 a tonne respectively.</p>\n<p>Looking at the day ahead, this morning the only data due out is the June PPI print for the Euro area. This afternoon in the US June factory orders and final June revisions for durable and capital goods orders are expected as well as July vehicle sales data. Away from that the Fed’s Bowman is due to speak this evening while it’s another busy day for earnings with the likes of BP, <a href=\"https://laohu8.com/S/COP\">ConocoPhillips</a>, BMW and <a href=\"https://laohu8.com/S/AMGN\">Amgen</a> amongst those reporting.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-03 19:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Futures up: Dow 0.46%, S&P 0.37%, <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> 0.16%.</li>\n <li>Chinese gaming stocks listed in the U.S. slump in premarket trading.</li>\n <li><a href=\"https://laohu8.com/S/UA.C\">Under Armour</a>, Translate Bio, <a href=\"https://laohu8.com/S/CLX\">Clorox</a> and more made the biggest moves in the premarket.</li>\n <li>Crude oil reversed earlier losses as sentiment improved in broader markets.</li>\n</ul>\n<p>(August 3) U.S. stock index futures rose on Tuesday, as an upbeat corporate earnings season and a pickup in global deals activity lifted demand for risky equities, although gains were capped by concerns around a surge in the Delta variant of the coronavirus.</p>\n<p>At 08:02 a.m. ET, Dow E-minis were up 159 points, or 0.46%, S&P 500 E-minis were up 16 points, or 0.37% and Nasdaq 100 E-minis rose 24.5 points, or 0.16%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/041b88ace41d9b6a718971a4da2e78b4\" tg-width=\"1242\" tg-height=\"484\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:02</span></p>\n<p>The big story overnight was <a href=\"https://laohu8.com/S/CAAS\">China</a>'s latest crackdown in which the XInhua-affiliated Economic <a href=\"https://laohu8.com/S/III\">Information</a> Daily cited Tencent's \"Honor of Kings\" in an article in which it said minors were addicted to online games and called for more curbs on the industry. The broadside re-ignited investor fears about state intervention in China after Beijing had already targeted the property, education and technology sectors to curb cost pressures and reassert the primacy of socialism after years of runaway market growth. \"They don’t believe anything is off limit and will react, sometimes overreact, to anything on state media that fits the tech crackdown narrative,” Ether Yin, partner at Trivium, a Beijing-based consultancy.</p>\n<p>Not surprisingly, Chinese gaming stocks listed in the U.S. slump in premarket trading; among the biggest gaming-related stocks falling this morning, <a href=\"https://laohu8.com/S/NTES\">NetEase</a> sinks 8.8%, Bilibili falls 6.67%, Huya declines 4.79% and <a href=\"https://laohu8.com/S/DOYU\">DouYu</a> International slides 5.12% as of 8:11am in <a href=\"https://laohu8.com/S/NWY\">New York</a>, Other large-cap Chinese stocks are also lower in U.S. premarket trading: <a href=\"https://laohu8.com/S/BABA\">Alibaba</a> -0.94%, Pinduoduo -1.2%, Baidu -0.37%, Didi -1.25%.</p>\n<p><img src=\"https://static.tigerbbs.com/7d28ab254bf7e852d939886a935a67a2\" tg-width=\"373\" tg-height=\"642\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves in the premarket: <a href=\"https://laohu8.com/S/UA\">Under Armour</a>, Translate Bio, Clorox and more</b></p>\n<p><b>1) Under Armour(UAA)</b> – Under Armour shares jumped 4.5% in the premarket, after the athletic apparel maker beat estimates on the top and bottom lines and the company raised its full-year forecast. Under Armour reported quarterly earnings of 24 cents per share, compared to a consensus estimate of 6 cents a share.</p>\n<p><b>2) Translate Bio(TBIO)</b> – French drugmakerSanofi(SNY) agreed to buy the U.S.-based biotech company for $3.2 billion, or $38 per share in cash. Translate Bio specializes in mRNA technology, the type that was used to produce thePfizerandModernaCovid-19 vaccines. Translate Bio shares soared 29.6% in premarket trading.</p>\n<p><b>3) Clorox(CLX) </b>– Clorox tumbled 8.6% in premarket action after the household products maker missed top and bottom line estimates for its latest quarter. Clorox’s sales fell from a year ago, when consumers stocked up on its products amid the surging pandemic.</p>\n<p><b>4) Eli Lilly(LLY) </b>– The drugmaker’s shares lost 1.7% in premarket trading, after falling 2 cents a share shy of estimates, with quarterly earnings of $1.87 per share. Revenue beat forecasts, but Lilly’s overall results were impacted by weaker sales of Covid-19 therapies as more Americans got vaccinated.</p>\n<p><b>5) <a href=\"https://laohu8.com/S/MAR\">Marriott</a>(MAR)</b> – The hotel operator’s stock gained 1.8% in premarket trading after it reported quarterly earnings of 79 cents per share, compared to a 45 cents a share consensus estimate. Revenue more than doubled from a year ago thanks to a rebound in travel demand, though it did fall slightly short of Wall Street forecasts.</p>\n<p><b>6) <a href=\"https://laohu8.com/S/TTWO\">Take-Two</a> Interactive(TTWO)</b> – Take-<a href=\"https://laohu8.com/S/TWOA.U\">Two</a> lost 4.3% premarket trading after issuing a weaker-than-expected outlook and announcing delays in new releases for some of its games. The video game producer beat estimates by 12 cents a share, with quarterly profit of $1.01 per share. Take-<a href=\"https://laohu8.com/S/TWOA\">Two</a>’s revenue also topped Wall Street forecasts.</p>\n<p><b>7) BP(BP)</b> – BP surged 6.3% in premarket trading after it reported better-than-expected quarterly profit and revenue, thanks to higher oil and gas prices. The energy producer also announced a 4% dividend hike and a boost to its share buyback program.</p>\n<p><b>8) Stellantis(STLA) </b>– Stellantis raised its full-year profit margin outlook after the automaker reported strong first-half financial results, boosted by record margins in North America. The upbeat results came despite the impact of the global chip shortage which cut production by 700,000 vehicles. The stock rallied 5.3% in the premarket.</p>\n<p><b>9) <a href=\"https://laohu8.com/S/MU\">Micron Technology</a>(MU)</b> – Micron instituted its first-ever dividend, with the chip maker planning to pay 10 cents per share in cash payable on October 18. Micron also said it had updated its share buyback policy to buy more when prices are low and fewer when prices are high. Micron shares gained 1.9% in the premarket.</p>\n<p><b>10) <a href=\"https://laohu8.com/S/SPG\">Simon Property</a> Group(SPG)</b> – Simon Property shares rose 2.8% in premarket trading after it said sales at its shopping centers returned to pre-pandemic levels in June. The largest U.S. mall owner is hoping the improved results encourage retailers to sign new leases and help it fill space vacated during the pandemic.</p>\n<p><b>11) <a href=\"https://laohu8.com/S/SEDG\">SolarEdge</a> Technologies(SEDG) </b>– SolarEdge reported better-than-expected earnings and revenue for its latest quarter, with the solar energy company also providing an upbeat current-quarter forecast. SolarEdge surged 11.4% in the premarket.</p>\n<p><b>12) Reynolds Consumer Products(REYN)</b> – Reynolds beat estimates by a penny a share, with quarterly earnings of 39 cents per share. Revenue fell short of Street forecasts, however. The maker of products like Hefty garbage bags and Reynolds Wrap said it was pleased with the results in the face of higher input costs supply chain issues. Reynolds lost 3.6% in premarket action.</p>\n<p><b>In rates,</b> treasuries drifted lower over early European session, tracking losses in bunds and gilts. The 10-year U.S. Treasury yield edged around 2bps higher after falling as low as 1.15%; the move steepened 2s10s, 5s30s by 1bp each. Higher S&P futures also added pressure on rising yields, following gains across European stocks amid positive earnings results. Germany’s 10-year yield fell to its lowest since early February at -0.486%. It was last up less than a basis point at -0.47%. Its 30-year yield, which turned negative and sent the whole German yield curve into negative territory on Monday, was hovering around 0%.</p>\n<p>“There is some definite downside bias in the dollar now,” said Vasileios Gkionakis, Global Head of FX Strategy at fund manager Lombard Odier in Switzerland. “You are starting to a see a rotation of growth away from the U.S.”</p>\n<p>According to strategists the months-long advance in Treasuries which saw 10Y real yields drop to fresh record lows on Monday, points to worries that a weaker period lies ahead for the economic reopening from the health crisis, though second-quarter corporate earnings have been robust for the most part. Traders are awaiting key U.S. jobs data this week to gauge the recovery and monitoring the impact of price pressures sparked by pandemic-related disruption and bottlenecks.</p>\n<p>“I don’t think the market is concerned about delta as much as it’s concerned about how it impacts inflation,” Shana Sissel, Spotlight Asset Group chief investment officer, said on Bloomberg Television, referring to the coronavirus variant. “The longer we have delta spread globally, the longer the supply chain disruptions will continue.”</p>\n<p>Meanwhile, on the policy front, the tapering debate continues. Federal Reserve Governor Christopher Waller said he could back a tapering announcement by September, if the next two monthly U.S. employment reports show continued gains.</p>\n<p><b>In FX, </b>the Norwegian krone and <a href=\"https://laohu8.com/S/NGD\">New</a> Zealand’s dollar led an advance against the greenback; the Canadian dollar retreated, underperforming its peers. The euro eked out an advance to a session high of 1.1885 per dollar; the pound climbed back above $1.39 and gilts halted a three-day gain as caution reigns ahead of Bank of England’s meeting on Thursday.<b>The Australian dollar jumped after the nation’s central bank said it will stick to its tapering plan, arguing that the economy will rebound from the latest virus outbreak.</b>Traders rushed to close short positions on the Aussie after the Reserve Bank of Australia decision on Tuesday, according to Asia-based FX traders. Existing AUD/NZD flows after the RBA decision propelled New Zealand’s dollar to a new session high.</p>\n<p>Australia’s currency advanced after its central bank kept a plan to taper bond purchases despite a protracted lockdown in Sydney.</p>\n<p><b>In commodities, </b>crude oil reversed earlier losses as sentiment improved in broader markets even though the spread of the delta coronavirus variant, including in the key market of China, continues to pose a risk to demand. Brent crude was up 33 cents in London at $73.28 per barrel. U.S. crude inched up to $71.56 a barrel while gold and industrial metal copper were both slightly lower at $1,810.45 per ounce and 9,594.50 a tonne respectively.</p>\n<p>Looking at the day ahead, this morning the only data due out is the June PPI print for the Euro area. This afternoon in the US June factory orders and final June revisions for durable and capital goods orders are expected as well as July vehicle sales data. Away from that the Fed’s Bowman is due to speak this evening while it’s another busy day for earnings with the likes of BP, <a href=\"https://laohu8.com/S/COP\">ConocoPhillips</a>, BMW and <a href=\"https://laohu8.com/S/AMGN\">Amgen</a> amongst those reporting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/318dced6c8505427ba4c5a73eb4a7981","relate_stocks":{".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126095878","content_text":"Futures up: Dow 0.46%, S&P 0.37%, Nasdaq 0.16%.\nChinese gaming stocks listed in the U.S. slump in premarket trading.\nUnder Armour, Translate Bio, Clorox and more made the biggest moves in the premarket.\nCrude oil reversed earlier losses as sentiment improved in broader markets.\n\n(August 3) U.S. stock index futures rose on Tuesday, as an upbeat corporate earnings season and a pickup in global deals activity lifted demand for risky equities, although gains were capped by concerns around a surge in the Delta variant of the coronavirus.\nAt 08:02 a.m. ET, Dow E-minis were up 159 points, or 0.46%, S&P 500 E-minis were up 16 points, or 0.37% and Nasdaq 100 E-minis rose 24.5 points, or 0.16%.\n*Source From Tiger Trade, EST 08:02\nThe big story overnight was China's latest crackdown in which the XInhua-affiliated Economic Information Daily cited Tencent's \"Honor of Kings\" in an article in which it said minors were addicted to online games and called for more curbs on the industry. The broadside re-ignited investor fears about state intervention in China after Beijing had already targeted the property, education and technology sectors to curb cost pressures and reassert the primacy of socialism after years of runaway market growth. \"They don’t believe anything is off limit and will react, sometimes overreact, to anything on state media that fits the tech crackdown narrative,” Ether Yin, partner at Trivium, a Beijing-based consultancy.\nNot surprisingly, Chinese gaming stocks listed in the U.S. slump in premarket trading; among the biggest gaming-related stocks falling this morning, NetEase sinks 8.8%, Bilibili falls 6.67%, Huya declines 4.79% and DouYu International slides 5.12% as of 8:11am in New York, Other large-cap Chinese stocks are also lower in U.S. premarket trading: Alibaba -0.94%, Pinduoduo -1.2%, Baidu -0.37%, Didi -1.25%.\n\nStocks making the biggest moves in the premarket: Under Armour, Translate Bio, Clorox and more\n1) Under Armour(UAA) – Under Armour shares jumped 4.5% in the premarket, after the athletic apparel maker beat estimates on the top and bottom lines and the company raised its full-year forecast. Under Armour reported quarterly earnings of 24 cents per share, compared to a consensus estimate of 6 cents a share.\n2) Translate Bio(TBIO) – French drugmakerSanofi(SNY) agreed to buy the U.S.-based biotech company for $3.2 billion, or $38 per share in cash. Translate Bio specializes in mRNA technology, the type that was used to produce thePfizerandModernaCovid-19 vaccines. Translate Bio shares soared 29.6% in premarket trading.\n3) Clorox(CLX) – Clorox tumbled 8.6% in premarket action after the household products maker missed top and bottom line estimates for its latest quarter. Clorox’s sales fell from a year ago, when consumers stocked up on its products amid the surging pandemic.\n4) Eli Lilly(LLY) – The drugmaker’s shares lost 1.7% in premarket trading, after falling 2 cents a share shy of estimates, with quarterly earnings of $1.87 per share. Revenue beat forecasts, but Lilly’s overall results were impacted by weaker sales of Covid-19 therapies as more Americans got vaccinated.\n5) Marriott(MAR) – The hotel operator’s stock gained 1.8% in premarket trading after it reported quarterly earnings of 79 cents per share, compared to a 45 cents a share consensus estimate. Revenue more than doubled from a year ago thanks to a rebound in travel demand, though it did fall slightly short of Wall Street forecasts.\n6) Take-Two Interactive(TTWO) – Take-Two lost 4.3% premarket trading after issuing a weaker-than-expected outlook and announcing delays in new releases for some of its games. The video game producer beat estimates by 12 cents a share, with quarterly profit of $1.01 per share. Take-Two’s revenue also topped Wall Street forecasts.\n7) BP(BP) – BP surged 6.3% in premarket trading after it reported better-than-expected quarterly profit and revenue, thanks to higher oil and gas prices. The energy producer also announced a 4% dividend hike and a boost to its share buyback program.\n8) Stellantis(STLA) – Stellantis raised its full-year profit margin outlook after the automaker reported strong first-half financial results, boosted by record margins in North America. The upbeat results came despite the impact of the global chip shortage which cut production by 700,000 vehicles. The stock rallied 5.3% in the premarket.\n9) Micron Technology(MU) – Micron instituted its first-ever dividend, with the chip maker planning to pay 10 cents per share in cash payable on October 18. Micron also said it had updated its share buyback policy to buy more when prices are low and fewer when prices are high. Micron shares gained 1.9% in the premarket.\n10) Simon Property Group(SPG) – Simon Property shares rose 2.8% in premarket trading after it said sales at its shopping centers returned to pre-pandemic levels in June. The largest U.S. mall owner is hoping the improved results encourage retailers to sign new leases and help it fill space vacated during the pandemic.\n11) SolarEdge Technologies(SEDG) – SolarEdge reported better-than-expected earnings and revenue for its latest quarter, with the solar energy company also providing an upbeat current-quarter forecast. SolarEdge surged 11.4% in the premarket.\n12) Reynolds Consumer Products(REYN) – Reynolds beat estimates by a penny a share, with quarterly earnings of 39 cents per share. Revenue fell short of Street forecasts, however. The maker of products like Hefty garbage bags and Reynolds Wrap said it was pleased with the results in the face of higher input costs supply chain issues. Reynolds lost 3.6% in premarket action.\nIn rates, treasuries drifted lower over early European session, tracking losses in bunds and gilts. The 10-year U.S. Treasury yield edged around 2bps higher after falling as low as 1.15%; the move steepened 2s10s, 5s30s by 1bp each. Higher S&P futures also added pressure on rising yields, following gains across European stocks amid positive earnings results. Germany’s 10-year yield fell to its lowest since early February at -0.486%. It was last up less than a basis point at -0.47%. Its 30-year yield, which turned negative and sent the whole German yield curve into negative territory on Monday, was hovering around 0%.\n“There is some definite downside bias in the dollar now,” said Vasileios Gkionakis, Global Head of FX Strategy at fund manager Lombard Odier in Switzerland. “You are starting to a see a rotation of growth away from the U.S.”\nAccording to strategists the months-long advance in Treasuries which saw 10Y real yields drop to fresh record lows on Monday, points to worries that a weaker period lies ahead for the economic reopening from the health crisis, though second-quarter corporate earnings have been robust for the most part. Traders are awaiting key U.S. jobs data this week to gauge the recovery and monitoring the impact of price pressures sparked by pandemic-related disruption and bottlenecks.\n“I don’t think the market is concerned about delta as much as it’s concerned about how it impacts inflation,” Shana Sissel, Spotlight Asset Group chief investment officer, said on Bloomberg Television, referring to the coronavirus variant. “The longer we have delta spread globally, the longer the supply chain disruptions will continue.”\nMeanwhile, on the policy front, the tapering debate continues. Federal Reserve Governor Christopher Waller said he could back a tapering announcement by September, if the next two monthly U.S. employment reports show continued gains.\nIn FX, the Norwegian krone and New Zealand’s dollar led an advance against the greenback; the Canadian dollar retreated, underperforming its peers. The euro eked out an advance to a session high of 1.1885 per dollar; the pound climbed back above $1.39 and gilts halted a three-day gain as caution reigns ahead of Bank of England’s meeting on Thursday.The Australian dollar jumped after the nation’s central bank said it will stick to its tapering plan, arguing that the economy will rebound from the latest virus outbreak.Traders rushed to close short positions on the Aussie after the Reserve Bank of Australia decision on Tuesday, according to Asia-based FX traders. Existing AUD/NZD flows after the RBA decision propelled New Zealand’s dollar to a new session high.\nAustralia’s currency advanced after its central bank kept a plan to taper bond purchases despite a protracted lockdown in Sydney.\nIn commodities, crude oil reversed earlier losses as sentiment improved in broader markets even though the spread of the delta coronavirus variant, including in the key market of China, continues to pose a risk to demand. Brent crude was up 33 cents in London at $73.28 per barrel. U.S. crude inched up to $71.56 a barrel while gold and industrial metal copper were both slightly lower at $1,810.45 per ounce and 9,594.50 a tonne respectively.\nLooking at the day ahead, this morning the only data due out is the June PPI print for the Euro area. This afternoon in the US June factory orders and final June revisions for durable and capital goods orders are expected as well as July vehicle sales data. Away from that the Fed’s Bowman is due to speak this evening while it’s another busy day for earnings with the likes of BP, ConocoPhillips, BMW and Amgen amongst those reporting.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":484,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807913036,"gmtCreate":1627995781725,"gmtModify":1631889501871,"author":{"id":"4089870511727540","authorId":"4089870511727540","name":"jimcm","avatar":"https://static.tigerbbs.com/c32942224c09c28bda012467a9e0b80c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089870511727540","authorIdStr":"4089870511727540"},"themes":[],"htmlText":"Wtf","listText":"Wtf","text":"Wtf","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/807913036","repostId":"1126095878","repostType":4,"repost":{"id":"1126095878","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1627991741,"share":"https://ttm.financial/m/news/1126095878?lang=&edition=full","pubTime":"2021-08-03 19:55","market":"us","language":"en","title":"Toplines Before US Market Open on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1126095878","media":"Tiger Newspress","summary":"Futures up: Dow 0.46%, S&P 0.37%, Nasdaq 0.16%.\nChinese gaming stocks listed in the U.S. slump in pr","content":"<ul>\n <li>Futures up: Dow 0.46%, S&P 0.37%, <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> 0.16%.</li>\n <li>Chinese gaming stocks listed in the U.S. slump in premarket trading.</li>\n <li><a href=\"https://laohu8.com/S/UA.C\">Under Armour</a>, Translate Bio, <a href=\"https://laohu8.com/S/CLX\">Clorox</a> and more made the biggest moves in the premarket.</li>\n <li>Crude oil reversed earlier losses as sentiment improved in broader markets.</li>\n</ul>\n<p>(August 3) U.S. stock index futures rose on Tuesday, as an upbeat corporate earnings season and a pickup in global deals activity lifted demand for risky equities, although gains were capped by concerns around a surge in the Delta variant of the coronavirus.</p>\n<p>At 08:02 a.m. ET, Dow E-minis were up 159 points, or 0.46%, S&P 500 E-minis were up 16 points, or 0.37% and Nasdaq 100 E-minis rose 24.5 points, or 0.16%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/041b88ace41d9b6a718971a4da2e78b4\" tg-width=\"1242\" tg-height=\"484\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:02</span></p>\n<p>The big story overnight was <a href=\"https://laohu8.com/S/CAAS\">China</a>'s latest crackdown in which the XInhua-affiliated Economic <a href=\"https://laohu8.com/S/III\">Information</a> Daily cited Tencent's \"Honor of Kings\" in an article in which it said minors were addicted to online games and called for more curbs on the industry. The broadside re-ignited investor fears about state intervention in China after Beijing had already targeted the property, education and technology sectors to curb cost pressures and reassert the primacy of socialism after years of runaway market growth. \"They don’t believe anything is off limit and will react, sometimes overreact, to anything on state media that fits the tech crackdown narrative,” Ether Yin, partner at Trivium, a Beijing-based consultancy.</p>\n<p>Not surprisingly, Chinese gaming stocks listed in the U.S. slump in premarket trading; among the biggest gaming-related stocks falling this morning, <a href=\"https://laohu8.com/S/NTES\">NetEase</a> sinks 8.8%, Bilibili falls 6.67%, Huya declines 4.79% and <a href=\"https://laohu8.com/S/DOYU\">DouYu</a> International slides 5.12% as of 8:11am in <a href=\"https://laohu8.com/S/NWY\">New York</a>, Other large-cap Chinese stocks are also lower in U.S. premarket trading: <a href=\"https://laohu8.com/S/BABA\">Alibaba</a> -0.94%, Pinduoduo -1.2%, Baidu -0.37%, Didi -1.25%.</p>\n<p><img src=\"https://static.tigerbbs.com/7d28ab254bf7e852d939886a935a67a2\" tg-width=\"373\" tg-height=\"642\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves in the premarket: <a href=\"https://laohu8.com/S/UA\">Under Armour</a>, Translate Bio, Clorox and more</b></p>\n<p><b>1) Under Armour(UAA)</b> – Under Armour shares jumped 4.5% in the premarket, after the athletic apparel maker beat estimates on the top and bottom lines and the company raised its full-year forecast. Under Armour reported quarterly earnings of 24 cents per share, compared to a consensus estimate of 6 cents a share.</p>\n<p><b>2) Translate Bio(TBIO)</b> – French drugmakerSanofi(SNY) agreed to buy the U.S.-based biotech company for $3.2 billion, or $38 per share in cash. Translate Bio specializes in mRNA technology, the type that was used to produce thePfizerandModernaCovid-19 vaccines. Translate Bio shares soared 29.6% in premarket trading.</p>\n<p><b>3) Clorox(CLX) </b>– Clorox tumbled 8.6% in premarket action after the household products maker missed top and bottom line estimates for its latest quarter. Clorox’s sales fell from a year ago, when consumers stocked up on its products amid the surging pandemic.</p>\n<p><b>4) Eli Lilly(LLY) </b>– The drugmaker’s shares lost 1.7% in premarket trading, after falling 2 cents a share shy of estimates, with quarterly earnings of $1.87 per share. Revenue beat forecasts, but Lilly’s overall results were impacted by weaker sales of Covid-19 therapies as more Americans got vaccinated.</p>\n<p><b>5) <a href=\"https://laohu8.com/S/MAR\">Marriott</a>(MAR)</b> – The hotel operator’s stock gained 1.8% in premarket trading after it reported quarterly earnings of 79 cents per share, compared to a 45 cents a share consensus estimate. Revenue more than doubled from a year ago thanks to a rebound in travel demand, though it did fall slightly short of Wall Street forecasts.</p>\n<p><b>6) <a href=\"https://laohu8.com/S/TTWO\">Take-Two</a> Interactive(TTWO)</b> – Take-<a href=\"https://laohu8.com/S/TWOA.U\">Two</a> lost 4.3% premarket trading after issuing a weaker-than-expected outlook and announcing delays in new releases for some of its games. The video game producer beat estimates by 12 cents a share, with quarterly profit of $1.01 per share. Take-<a href=\"https://laohu8.com/S/TWOA\">Two</a>’s revenue also topped Wall Street forecasts.</p>\n<p><b>7) BP(BP)</b> – BP surged 6.3% in premarket trading after it reported better-than-expected quarterly profit and revenue, thanks to higher oil and gas prices. The energy producer also announced a 4% dividend hike and a boost to its share buyback program.</p>\n<p><b>8) Stellantis(STLA) </b>– Stellantis raised its full-year profit margin outlook after the automaker reported strong first-half financial results, boosted by record margins in North America. The upbeat results came despite the impact of the global chip shortage which cut production by 700,000 vehicles. The stock rallied 5.3% in the premarket.</p>\n<p><b>9) <a href=\"https://laohu8.com/S/MU\">Micron Technology</a>(MU)</b> – Micron instituted its first-ever dividend, with the chip maker planning to pay 10 cents per share in cash payable on October 18. Micron also said it had updated its share buyback policy to buy more when prices are low and fewer when prices are high. Micron shares gained 1.9% in the premarket.</p>\n<p><b>10) <a href=\"https://laohu8.com/S/SPG\">Simon Property</a> Group(SPG)</b> – Simon Property shares rose 2.8% in premarket trading after it said sales at its shopping centers returned to pre-pandemic levels in June. The largest U.S. mall owner is hoping the improved results encourage retailers to sign new leases and help it fill space vacated during the pandemic.</p>\n<p><b>11) <a href=\"https://laohu8.com/S/SEDG\">SolarEdge</a> Technologies(SEDG) </b>– SolarEdge reported better-than-expected earnings and revenue for its latest quarter, with the solar energy company also providing an upbeat current-quarter forecast. SolarEdge surged 11.4% in the premarket.</p>\n<p><b>12) Reynolds Consumer Products(REYN)</b> – Reynolds beat estimates by a penny a share, with quarterly earnings of 39 cents per share. Revenue fell short of Street forecasts, however. The maker of products like Hefty garbage bags and Reynolds Wrap said it was pleased with the results in the face of higher input costs supply chain issues. Reynolds lost 3.6% in premarket action.</p>\n<p><b>In rates,</b> treasuries drifted lower over early European session, tracking losses in bunds and gilts. The 10-year U.S. Treasury yield edged around 2bps higher after falling as low as 1.15%; the move steepened 2s10s, 5s30s by 1bp each. Higher S&P futures also added pressure on rising yields, following gains across European stocks amid positive earnings results. Germany’s 10-year yield fell to its lowest since early February at -0.486%. It was last up less than a basis point at -0.47%. Its 30-year yield, which turned negative and sent the whole German yield curve into negative territory on Monday, was hovering around 0%.</p>\n<p>“There is some definite downside bias in the dollar now,” said Vasileios Gkionakis, Global Head of FX Strategy at fund manager Lombard Odier in Switzerland. “You are starting to a see a rotation of growth away from the U.S.”</p>\n<p>According to strategists the months-long advance in Treasuries which saw 10Y real yields drop to fresh record lows on Monday, points to worries that a weaker period lies ahead for the economic reopening from the health crisis, though second-quarter corporate earnings have been robust for the most part. Traders are awaiting key U.S. jobs data this week to gauge the recovery and monitoring the impact of price pressures sparked by pandemic-related disruption and bottlenecks.</p>\n<p>“I don’t think the market is concerned about delta as much as it’s concerned about how it impacts inflation,” Shana Sissel, Spotlight Asset Group chief investment officer, said on Bloomberg Television, referring to the coronavirus variant. “The longer we have delta spread globally, the longer the supply chain disruptions will continue.”</p>\n<p>Meanwhile, on the policy front, the tapering debate continues. Federal Reserve Governor Christopher Waller said he could back a tapering announcement by September, if the next two monthly U.S. employment reports show continued gains.</p>\n<p><b>In FX, </b>the Norwegian krone and <a href=\"https://laohu8.com/S/NGD\">New</a> Zealand’s dollar led an advance against the greenback; the Canadian dollar retreated, underperforming its peers. The euro eked out an advance to a session high of 1.1885 per dollar; the pound climbed back above $1.39 and gilts halted a three-day gain as caution reigns ahead of Bank of England’s meeting on Thursday.<b>The Australian dollar jumped after the nation’s central bank said it will stick to its tapering plan, arguing that the economy will rebound from the latest virus outbreak.</b>Traders rushed to close short positions on the Aussie after the Reserve Bank of Australia decision on Tuesday, according to Asia-based FX traders. Existing AUD/NZD flows after the RBA decision propelled New Zealand’s dollar to a new session high.</p>\n<p>Australia’s currency advanced after its central bank kept a plan to taper bond purchases despite a protracted lockdown in Sydney.</p>\n<p><b>In commodities, </b>crude oil reversed earlier losses as sentiment improved in broader markets even though the spread of the delta coronavirus variant, including in the key market of China, continues to pose a risk to demand. Brent crude was up 33 cents in London at $73.28 per barrel. U.S. crude inched up to $71.56 a barrel while gold and industrial metal copper were both slightly lower at $1,810.45 per ounce and 9,594.50 a tonne respectively.</p>\n<p>Looking at the day ahead, this morning the only data due out is the June PPI print for the Euro area. This afternoon in the US June factory orders and final June revisions for durable and capital goods orders are expected as well as July vehicle sales data. Away from that the Fed’s Bowman is due to speak this evening while it’s another busy day for earnings with the likes of BP, <a href=\"https://laohu8.com/S/COP\">ConocoPhillips</a>, BMW and <a href=\"https://laohu8.com/S/AMGN\">Amgen</a> amongst those reporting.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-03 19:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Futures up: Dow 0.46%, S&P 0.37%, <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> 0.16%.</li>\n <li>Chinese gaming stocks listed in the U.S. slump in premarket trading.</li>\n <li><a href=\"https://laohu8.com/S/UA.C\">Under Armour</a>, Translate Bio, <a href=\"https://laohu8.com/S/CLX\">Clorox</a> and more made the biggest moves in the premarket.</li>\n <li>Crude oil reversed earlier losses as sentiment improved in broader markets.</li>\n</ul>\n<p>(August 3) U.S. stock index futures rose on Tuesday, as an upbeat corporate earnings season and a pickup in global deals activity lifted demand for risky equities, although gains were capped by concerns around a surge in the Delta variant of the coronavirus.</p>\n<p>At 08:02 a.m. ET, Dow E-minis were up 159 points, or 0.46%, S&P 500 E-minis were up 16 points, or 0.37% and Nasdaq 100 E-minis rose 24.5 points, or 0.16%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/041b88ace41d9b6a718971a4da2e78b4\" tg-width=\"1242\" tg-height=\"484\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:02</span></p>\n<p>The big story overnight was <a href=\"https://laohu8.com/S/CAAS\">China</a>'s latest crackdown in which the XInhua-affiliated Economic <a href=\"https://laohu8.com/S/III\">Information</a> Daily cited Tencent's \"Honor of Kings\" in an article in which it said minors were addicted to online games and called for more curbs on the industry. The broadside re-ignited investor fears about state intervention in China after Beijing had already targeted the property, education and technology sectors to curb cost pressures and reassert the primacy of socialism after years of runaway market growth. \"They don’t believe anything is off limit and will react, sometimes overreact, to anything on state media that fits the tech crackdown narrative,” Ether Yin, partner at Trivium, a Beijing-based consultancy.</p>\n<p>Not surprisingly, Chinese gaming stocks listed in the U.S. slump in premarket trading; among the biggest gaming-related stocks falling this morning, <a href=\"https://laohu8.com/S/NTES\">NetEase</a> sinks 8.8%, Bilibili falls 6.67%, Huya declines 4.79% and <a href=\"https://laohu8.com/S/DOYU\">DouYu</a> International slides 5.12% as of 8:11am in <a href=\"https://laohu8.com/S/NWY\">New York</a>, Other large-cap Chinese stocks are also lower in U.S. premarket trading: <a href=\"https://laohu8.com/S/BABA\">Alibaba</a> -0.94%, Pinduoduo -1.2%, Baidu -0.37%, Didi -1.25%.</p>\n<p><img src=\"https://static.tigerbbs.com/7d28ab254bf7e852d939886a935a67a2\" tg-width=\"373\" tg-height=\"642\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves in the premarket: <a href=\"https://laohu8.com/S/UA\">Under Armour</a>, Translate Bio, Clorox and more</b></p>\n<p><b>1) Under Armour(UAA)</b> – Under Armour shares jumped 4.5% in the premarket, after the athletic apparel maker beat estimates on the top and bottom lines and the company raised its full-year forecast. Under Armour reported quarterly earnings of 24 cents per share, compared to a consensus estimate of 6 cents a share.</p>\n<p><b>2) Translate Bio(TBIO)</b> – French drugmakerSanofi(SNY) agreed to buy the U.S.-based biotech company for $3.2 billion, or $38 per share in cash. Translate Bio specializes in mRNA technology, the type that was used to produce thePfizerandModernaCovid-19 vaccines. Translate Bio shares soared 29.6% in premarket trading.</p>\n<p><b>3) Clorox(CLX) </b>– Clorox tumbled 8.6% in premarket action after the household products maker missed top and bottom line estimates for its latest quarter. Clorox’s sales fell from a year ago, when consumers stocked up on its products amid the surging pandemic.</p>\n<p><b>4) Eli Lilly(LLY) </b>– The drugmaker’s shares lost 1.7% in premarket trading, after falling 2 cents a share shy of estimates, with quarterly earnings of $1.87 per share. Revenue beat forecasts, but Lilly’s overall results were impacted by weaker sales of Covid-19 therapies as more Americans got vaccinated.</p>\n<p><b>5) <a href=\"https://laohu8.com/S/MAR\">Marriott</a>(MAR)</b> – The hotel operator’s stock gained 1.8% in premarket trading after it reported quarterly earnings of 79 cents per share, compared to a 45 cents a share consensus estimate. Revenue more than doubled from a year ago thanks to a rebound in travel demand, though it did fall slightly short of Wall Street forecasts.</p>\n<p><b>6) <a href=\"https://laohu8.com/S/TTWO\">Take-Two</a> Interactive(TTWO)</b> – Take-<a href=\"https://laohu8.com/S/TWOA.U\">Two</a> lost 4.3% premarket trading after issuing a weaker-than-expected outlook and announcing delays in new releases for some of its games. The video game producer beat estimates by 12 cents a share, with quarterly profit of $1.01 per share. Take-<a href=\"https://laohu8.com/S/TWOA\">Two</a>’s revenue also topped Wall Street forecasts.</p>\n<p><b>7) BP(BP)</b> – BP surged 6.3% in premarket trading after it reported better-than-expected quarterly profit and revenue, thanks to higher oil and gas prices. The energy producer also announced a 4% dividend hike and a boost to its share buyback program.</p>\n<p><b>8) Stellantis(STLA) </b>– Stellantis raised its full-year profit margin outlook after the automaker reported strong first-half financial results, boosted by record margins in North America. The upbeat results came despite the impact of the global chip shortage which cut production by 700,000 vehicles. The stock rallied 5.3% in the premarket.</p>\n<p><b>9) <a href=\"https://laohu8.com/S/MU\">Micron Technology</a>(MU)</b> – Micron instituted its first-ever dividend, with the chip maker planning to pay 10 cents per share in cash payable on October 18. Micron also said it had updated its share buyback policy to buy more when prices are low and fewer when prices are high. Micron shares gained 1.9% in the premarket.</p>\n<p><b>10) <a href=\"https://laohu8.com/S/SPG\">Simon Property</a> Group(SPG)</b> – Simon Property shares rose 2.8% in premarket trading after it said sales at its shopping centers returned to pre-pandemic levels in June. The largest U.S. mall owner is hoping the improved results encourage retailers to sign new leases and help it fill space vacated during the pandemic.</p>\n<p><b>11) <a href=\"https://laohu8.com/S/SEDG\">SolarEdge</a> Technologies(SEDG) </b>– SolarEdge reported better-than-expected earnings and revenue for its latest quarter, with the solar energy company also providing an upbeat current-quarter forecast. SolarEdge surged 11.4% in the premarket.</p>\n<p><b>12) Reynolds Consumer Products(REYN)</b> – Reynolds beat estimates by a penny a share, with quarterly earnings of 39 cents per share. Revenue fell short of Street forecasts, however. The maker of products like Hefty garbage bags and Reynolds Wrap said it was pleased with the results in the face of higher input costs supply chain issues. Reynolds lost 3.6% in premarket action.</p>\n<p><b>In rates,</b> treasuries drifted lower over early European session, tracking losses in bunds and gilts. The 10-year U.S. Treasury yield edged around 2bps higher after falling as low as 1.15%; the move steepened 2s10s, 5s30s by 1bp each. Higher S&P futures also added pressure on rising yields, following gains across European stocks amid positive earnings results. Germany’s 10-year yield fell to its lowest since early February at -0.486%. It was last up less than a basis point at -0.47%. Its 30-year yield, which turned negative and sent the whole German yield curve into negative territory on Monday, was hovering around 0%.</p>\n<p>“There is some definite downside bias in the dollar now,” said Vasileios Gkionakis, Global Head of FX Strategy at fund manager Lombard Odier in Switzerland. “You are starting to a see a rotation of growth away from the U.S.”</p>\n<p>According to strategists the months-long advance in Treasuries which saw 10Y real yields drop to fresh record lows on Monday, points to worries that a weaker period lies ahead for the economic reopening from the health crisis, though second-quarter corporate earnings have been robust for the most part. Traders are awaiting key U.S. jobs data this week to gauge the recovery and monitoring the impact of price pressures sparked by pandemic-related disruption and bottlenecks.</p>\n<p>“I don’t think the market is concerned about delta as much as it’s concerned about how it impacts inflation,” Shana Sissel, Spotlight Asset Group chief investment officer, said on Bloomberg Television, referring to the coronavirus variant. “The longer we have delta spread globally, the longer the supply chain disruptions will continue.”</p>\n<p>Meanwhile, on the policy front, the tapering debate continues. Federal Reserve Governor Christopher Waller said he could back a tapering announcement by September, if the next two monthly U.S. employment reports show continued gains.</p>\n<p><b>In FX, </b>the Norwegian krone and <a href=\"https://laohu8.com/S/NGD\">New</a> Zealand’s dollar led an advance against the greenback; the Canadian dollar retreated, underperforming its peers. The euro eked out an advance to a session high of 1.1885 per dollar; the pound climbed back above $1.39 and gilts halted a three-day gain as caution reigns ahead of Bank of England’s meeting on Thursday.<b>The Australian dollar jumped after the nation’s central bank said it will stick to its tapering plan, arguing that the economy will rebound from the latest virus outbreak.</b>Traders rushed to close short positions on the Aussie after the Reserve Bank of Australia decision on Tuesday, according to Asia-based FX traders. Existing AUD/NZD flows after the RBA decision propelled New Zealand’s dollar to a new session high.</p>\n<p>Australia’s currency advanced after its central bank kept a plan to taper bond purchases despite a protracted lockdown in Sydney.</p>\n<p><b>In commodities, </b>crude oil reversed earlier losses as sentiment improved in broader markets even though the spread of the delta coronavirus variant, including in the key market of China, continues to pose a risk to demand. Brent crude was up 33 cents in London at $73.28 per barrel. U.S. crude inched up to $71.56 a barrel while gold and industrial metal copper were both slightly lower at $1,810.45 per ounce and 9,594.50 a tonne respectively.</p>\n<p>Looking at the day ahead, this morning the only data due out is the June PPI print for the Euro area. This afternoon in the US June factory orders and final June revisions for durable and capital goods orders are expected as well as July vehicle sales data. Away from that the Fed’s Bowman is due to speak this evening while it’s another busy day for earnings with the likes of BP, <a href=\"https://laohu8.com/S/COP\">ConocoPhillips</a>, BMW and <a href=\"https://laohu8.com/S/AMGN\">Amgen</a> amongst those reporting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/318dced6c8505427ba4c5a73eb4a7981","relate_stocks":{".DJI":"道琼斯","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126095878","content_text":"Futures up: Dow 0.46%, S&P 0.37%, Nasdaq 0.16%.\nChinese gaming stocks listed in the U.S. slump in premarket trading.\nUnder Armour, Translate Bio, Clorox and more made the biggest moves in the premarket.\nCrude oil reversed earlier losses as sentiment improved in broader markets.\n\n(August 3) U.S. stock index futures rose on Tuesday, as an upbeat corporate earnings season and a pickup in global deals activity lifted demand for risky equities, although gains were capped by concerns around a surge in the Delta variant of the coronavirus.\nAt 08:02 a.m. ET, Dow E-minis were up 159 points, or 0.46%, S&P 500 E-minis were up 16 points, or 0.37% and Nasdaq 100 E-minis rose 24.5 points, or 0.16%.\n*Source From Tiger Trade, EST 08:02\nThe big story overnight was China's latest crackdown in which the XInhua-affiliated Economic Information Daily cited Tencent's \"Honor of Kings\" in an article in which it said minors were addicted to online games and called for more curbs on the industry. The broadside re-ignited investor fears about state intervention in China after Beijing had already targeted the property, education and technology sectors to curb cost pressures and reassert the primacy of socialism after years of runaway market growth. \"They don’t believe anything is off limit and will react, sometimes overreact, to anything on state media that fits the tech crackdown narrative,” Ether Yin, partner at Trivium, a Beijing-based consultancy.\nNot surprisingly, Chinese gaming stocks listed in the U.S. slump in premarket trading; among the biggest gaming-related stocks falling this morning, NetEase sinks 8.8%, Bilibili falls 6.67%, Huya declines 4.79% and DouYu International slides 5.12% as of 8:11am in New York, Other large-cap Chinese stocks are also lower in U.S. premarket trading: Alibaba -0.94%, Pinduoduo -1.2%, Baidu -0.37%, Didi -1.25%.\n\nStocks making the biggest moves in the premarket: Under Armour, Translate Bio, Clorox and more\n1) Under Armour(UAA) – Under Armour shares jumped 4.5% in the premarket, after the athletic apparel maker beat estimates on the top and bottom lines and the company raised its full-year forecast. Under Armour reported quarterly earnings of 24 cents per share, compared to a consensus estimate of 6 cents a share.\n2) Translate Bio(TBIO) – French drugmakerSanofi(SNY) agreed to buy the U.S.-based biotech company for $3.2 billion, or $38 per share in cash. Translate Bio specializes in mRNA technology, the type that was used to produce thePfizerandModernaCovid-19 vaccines. Translate Bio shares soared 29.6% in premarket trading.\n3) Clorox(CLX) – Clorox tumbled 8.6% in premarket action after the household products maker missed top and bottom line estimates for its latest quarter. Clorox’s sales fell from a year ago, when consumers stocked up on its products amid the surging pandemic.\n4) Eli Lilly(LLY) – The drugmaker’s shares lost 1.7% in premarket trading, after falling 2 cents a share shy of estimates, with quarterly earnings of $1.87 per share. Revenue beat forecasts, but Lilly’s overall results were impacted by weaker sales of Covid-19 therapies as more Americans got vaccinated.\n5) Marriott(MAR) – The hotel operator’s stock gained 1.8% in premarket trading after it reported quarterly earnings of 79 cents per share, compared to a 45 cents a share consensus estimate. Revenue more than doubled from a year ago thanks to a rebound in travel demand, though it did fall slightly short of Wall Street forecasts.\n6) Take-Two Interactive(TTWO) – Take-Two lost 4.3% premarket trading after issuing a weaker-than-expected outlook and announcing delays in new releases for some of its games. The video game producer beat estimates by 12 cents a share, with quarterly profit of $1.01 per share. Take-Two’s revenue also topped Wall Street forecasts.\n7) BP(BP) – BP surged 6.3% in premarket trading after it reported better-than-expected quarterly profit and revenue, thanks to higher oil and gas prices. The energy producer also announced a 4% dividend hike and a boost to its share buyback program.\n8) Stellantis(STLA) – Stellantis raised its full-year profit margin outlook after the automaker reported strong first-half financial results, boosted by record margins in North America. The upbeat results came despite the impact of the global chip shortage which cut production by 700,000 vehicles. The stock rallied 5.3% in the premarket.\n9) Micron Technology(MU) – Micron instituted its first-ever dividend, with the chip maker planning to pay 10 cents per share in cash payable on October 18. Micron also said it had updated its share buyback policy to buy more when prices are low and fewer when prices are high. Micron shares gained 1.9% in the premarket.\n10) Simon Property Group(SPG) – Simon Property shares rose 2.8% in premarket trading after it said sales at its shopping centers returned to pre-pandemic levels in June. The largest U.S. mall owner is hoping the improved results encourage retailers to sign new leases and help it fill space vacated during the pandemic.\n11) SolarEdge Technologies(SEDG) – SolarEdge reported better-than-expected earnings and revenue for its latest quarter, with the solar energy company also providing an upbeat current-quarter forecast. SolarEdge surged 11.4% in the premarket.\n12) Reynolds Consumer Products(REYN) – Reynolds beat estimates by a penny a share, with quarterly earnings of 39 cents per share. Revenue fell short of Street forecasts, however. The maker of products like Hefty garbage bags and Reynolds Wrap said it was pleased with the results in the face of higher input costs supply chain issues. Reynolds lost 3.6% in premarket action.\nIn rates, treasuries drifted lower over early European session, tracking losses in bunds and gilts. The 10-year U.S. Treasury yield edged around 2bps higher after falling as low as 1.15%; the move steepened 2s10s, 5s30s by 1bp each. Higher S&P futures also added pressure on rising yields, following gains across European stocks amid positive earnings results. Germany’s 10-year yield fell to its lowest since early February at -0.486%. It was last up less than a basis point at -0.47%. Its 30-year yield, which turned negative and sent the whole German yield curve into negative territory on Monday, was hovering around 0%.\n“There is some definite downside bias in the dollar now,” said Vasileios Gkionakis, Global Head of FX Strategy at fund manager Lombard Odier in Switzerland. “You are starting to a see a rotation of growth away from the U.S.”\nAccording to strategists the months-long advance in Treasuries which saw 10Y real yields drop to fresh record lows on Monday, points to worries that a weaker period lies ahead for the economic reopening from the health crisis, though second-quarter corporate earnings have been robust for the most part. Traders are awaiting key U.S. jobs data this week to gauge the recovery and monitoring the impact of price pressures sparked by pandemic-related disruption and bottlenecks.\n“I don’t think the market is concerned about delta as much as it’s concerned about how it impacts inflation,” Shana Sissel, Spotlight Asset Group chief investment officer, said on Bloomberg Television, referring to the coronavirus variant. “The longer we have delta spread globally, the longer the supply chain disruptions will continue.”\nMeanwhile, on the policy front, the tapering debate continues. Federal Reserve Governor Christopher Waller said he could back a tapering announcement by September, if the next two monthly U.S. employment reports show continued gains.\nIn FX, the Norwegian krone and New Zealand’s dollar led an advance against the greenback; the Canadian dollar retreated, underperforming its peers. The euro eked out an advance to a session high of 1.1885 per dollar; the pound climbed back above $1.39 and gilts halted a three-day gain as caution reigns ahead of Bank of England’s meeting on Thursday.The Australian dollar jumped after the nation’s central bank said it will stick to its tapering plan, arguing that the economy will rebound from the latest virus outbreak.Traders rushed to close short positions on the Aussie after the Reserve Bank of Australia decision on Tuesday, according to Asia-based FX traders. Existing AUD/NZD flows after the RBA decision propelled New Zealand’s dollar to a new session high.\nAustralia’s currency advanced after its central bank kept a plan to taper bond purchases despite a protracted lockdown in Sydney.\nIn commodities, crude oil reversed earlier losses as sentiment improved in broader markets even though the spread of the delta coronavirus variant, including in the key market of China, continues to pose a risk to demand. Brent crude was up 33 cents in London at $73.28 per barrel. U.S. crude inched up to $71.56 a barrel while gold and industrial metal copper were both slightly lower at $1,810.45 per ounce and 9,594.50 a tonne respectively.\nLooking at the day ahead, this morning the only data due out is the June PPI print for the Euro area. This afternoon in the US June factory orders and final June revisions for durable and capital goods orders are expected as well as July vehicle sales data. Away from that the Fed’s Bowman is due to speak this evening while it’s another busy day for earnings with the likes of BP, ConocoPhillips, BMW and Amgen amongst those reporting.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":457,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}